Stay updated on Erythromycin for APC Stop Codon Mutations in FAP Clinical Trial
Sign up to get notified when there's something new on the Erythromycin for APC Stop Codon Mutations in FAP Clinical Trial page.

Latest updates to the Erythromycin for APC Stop Codon Mutations in FAP Clinical Trial page
- CheckyesterdayChange DetectedThe ClinicalTrials.gov site revision label changed from v3.8.0 to v3.8.1; the study details remain unchanged.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe page now displays the study record for an erythromycin trial in familial adenomatous polyposis, including its research aims, treatment plan, eligibility criteria, outcomes, contacts, and record history.SummaryDifference44%

- Check22 days agoChange DetectedThe footer revision number changes from v3.7.2 to v3.8.0 on the 403 error page.SummaryDifference0.2%

- Check29 days agoChange DetectedA notice about NIH website changes and the transition from “Artificial Intelligence” to “Super Intelligence” appears above the unavailable study record.SummaryDifference1%

- Check36 days agoChange DetectedThe site footer revision indicator changed from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check43 days agoChange DetectedThe site footer revision changed from v3.7.0 to v3.7.1; the page continues to display a 403 error.SummaryDifference0.2%

Stay in the know with updates to Erythromycin for APC Stop Codon Mutations in FAP Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Erythromycin for APC Stop Codon Mutations in FAP Clinical Trial page.